• Contact Us
  • New Tenders
  • Register
  • Login

Supply of Medicinal Products Based on the Decision of the Medical Commission (tn: Lamictal)

RussiaTenders notice for Supply of Medicinal Products Based on the Decision of the Medical Commission (tn: Lamictal). The reference ID of the tender is 50745889 and it is closing on 09 Mar 2021.

Tender Details

  • Country: Russia
  • Summary: Supply of Medicinal Products Based on the Decision of the Medical Commission (tn: Lamictal)
  • RUT Ref No: 50745889
  • Deadline: 09 Mar 2021
  • Financier: Self Financed
  • Purchaser Ownership: -
  • Tender Value: 55123.20
  • Notice Type: Tender
  • Document Ref. No.: 0303200025121000089
  • Purchaser's Detail:
  • Purchaser : MINISTRY OF HEALTH OF THE REPUBLIC OF DAGESTAN
    Russian Federation, 367912, Dagestan Resp, Makhachkala city, STREET ABUBAKAROVA, HOUSE 10
    Full name: - Isagadzhiev G.M.
    Contact phone number: - 7-8722-674886
    Fax: - No information available
    Email :mtomzrd@mail.ru

  • Description:
  • Supply of medicinal products based on the decision of the medical commission (TN: Lamictal)
  • Documents:

 Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN
RussiaTenders Features

RussiaTenders Features

Fresh and verified Tenders from Russia. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • Accurate Tender Information
  • New Tenders Every Day
  • Consultants for RFI/RFP/RFQ
  • Search, sort, and filter Tenders
  • Customer Support
  • Publish your Tenders
  • Consulting Services
  • Export data to Excel or CRM
Tender Experts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting ZimbabweTenders !!
Email Id is already exist !!
Captcha Image
Invalid Captcha !

Get FREE SAMPLE TENDERS from Russia in your email inbox.

  Chat with us